# Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain

> **NCT04903002** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial University of Newfoundland** · enrollment: 336 (estimated)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** 24-IU oxytocin
- **DRUG:** 48-IU oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04903002
- **Lead sponsor:** Memorial University of Newfoundland
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2026-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04903002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04903002, "Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04903002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*